EM
EMS Pharma
Hortolandia BRFounded 19647,000 employees
Private CappharmaPrivateOncologyCardiology
Platform: Generic Leader
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pexavorutinib | EMS-3367 | Phase 1/2 | 2 | Nectin-4 | EoEADHD | ||
| EMS-5854 | EMS-5854 | Phase 2 | 1 | KRASG12C | DLBCLMelanoma | ||
| Semafotisoran | EMS-1678 | Phase 1 | 2 | KRASG12C | RBMigraine |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)